As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...